Company SomnoMed Limited

Equities

SOM

AU000000SOM1

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 01:57:19 2024-04-26 am EDT 5-day change 1st Jan Change
0.21 AUD 0.00% Intraday chart for SomnoMed Limited +2.44% -58.00%

Business Summary

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Sleep Related Disorder Devices
100.0 %
73 100.0 % 84 100.0 % +15.20%

Sales per region

AUD in Million2022Weight2023Weight Delta
Europe
56.6 %
42 58.5 % 47 56.6 % +11.46%
North America
36.1 %
25 34.0 % 30 36.1 % +22.18%
Asia Pacific
7.3 %
5 7.5 % 6 7.3 % +12.76%

Managers

Managers TitleAgeSince
Chief Executive Officer - 20-08-23
Chief Executive Officer - 20-11-25
Director of Finance/CFO - 23-07-31
Chief Tech/Sci/R&D Officer - 20-08-31
Human Resources Officer - 21-03-31
- -
Corporate Officer/Principal - 21-06-30
Sales & Marketing - 19-06-30
Corporate Officer/Principal - 03-12-31
Corporate Secretary - 94-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 18-04-30
Chairman 65 20-08-23
Chief Executive Officer - 20-11-25
Director/Board Member - 20-08-23
Chief Executive Officer - 20-08-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 216,107,630 189,259,553 ( 87.58 %) 0 87.58 %

Shareholders

NameEquities%Valuation
TDMAM Pty Ltd.
30.00 %
32,572,382 30.00 % 8 M $
Dottie Investments Pty Ltd.
6.364 %
6,910,402 6.364 % 2 M $
Fidelity Management & Research Co. LLC
4.073 %
4,422,833 4.073 % 1 M $
Australian Ethical Investments Ltd. (Investment Management)
3.179 %
3,451,667 3.179 % 868 647 $
3,278,640 3.019 % 825 103 $
Howarth Paf Pty Ltd.
2.468 %
2,680,493 2.468 % 674 573 $
1,751,050 1.613 % 440 669 $
Ginga Pty Ltd.
1.601 %
1,739,045 1.601 % 437 648 $
Timbina Pty Ltd.
0.9888 %
1,073,764 0.9888 % 270 223 $
R.E.M. Medical Pty Ltd.
0.8437 %
916,150 0.8437 % 230 558 $

Company contact information

Somnomed Ltd.

20 Clarke Street Level 3

2065, Sydney

+61 2 9467 0400

http://www.somnomed.com
address SomnoMed Limited(SOM)
  1. Stock Market
  2. Equities
  3. SOM Stock
  4. Company SomnoMed Limited